Method to treat fatty liver disease using Parabacteroides goldsteinii
US10111915B1 · kind B1 · utility
1Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 16, 2017 |
| Grant date | Oct 30, 2018 |
| Priority date | — |
| Expiry date | Nov 16, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2035/115
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention describes a method to reduce blood aspartate transaminase level, liver weight, hepatic lipid accumulation and hepatocyte hypertrophy by administering the probiotic bacterium Parabacteroides goldsteinii to a subject showing signs of fatty liver disease. This probiotic bacterium can therefore be used to treat fatty liver disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.